2025 annual financial data
Vor Biopharma 2025 Net income growth
Direct answer
Net income growth was -495.29%.
Operating income was -371,642,000 USD and net income was -695,981,000 USD.
Operating cash flow was -142,713,000 USD.
Get free Vor Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -371,642,000 USD
- Net income
- -695,981,000 USD
- Operating cash flow
- -142,713,000 USD